Case report: Virus-induced hemophagocytic lymphohistiocytosis in a patient with APECED
Frontiers in Pediatrics · 15.02.2023 · 11
DOI: 10.3389/fped.2023.1086867 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 15.02.2023. Verfasst von Oksana Boyarchuk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Children's Diseases and Pediatric Surgery, I.Horbachevsky Ternopil National Medical University, Ternopil, Ukraine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), also known as autoimmune polyglandular syndrome type 1 (APS-1) is a rare autosomal recessive inborn error of immunity (IEI), which is accompanied by immune dysregulation. Hypoparathyroidism, adrenocortical failure and candidiasis are its typical manifestations. Here we report about recurrent COVID-19 in a 3-year-old boy with APECED, who developed retinopathy with macular atrophy and autoimmune hepatitis after the first episode of SARS-CoV-2 infection. Primary Epstein-Barr virus infection and a new episode of SARS-CoV-2 infection with COVID pneumonia triggered the development of severe hyperinflammation with signs of hemophagocytic lymphohistiocytosis (HLH): progressive cytopenia (thrombocytopenia, anemia, lymphopenia), hypoproteinemia, hypoalbuminemia, high levels of liver enzymes, hyperferritinemia, increased triglycerides levels; and coagulopathy with a low level of fibrinogen. Treatment with corticosteroids and intravenous immunoglobulins did not lead to a significant improvement. The progression of HLH and COVID-pneumonia resulted in a fatal outcome. The rarity and varied presentation of the HLH symptoms led to diagnostic difficulties and diagnosis delay. HLH should be suspected in a patient with immune dysregulation and impaired viral response. Treatment of infection-HLH is a major challenge due to the difficulties in balancing immunosuppression and management of underlying/triggering infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Children's Diseases and Pediatric Surgery, I.Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
- Municipal Children's Hospital, Ternopil, Ukraine.
- Department of Pediatrics, Pediatric Infectious Diseases, Immunology and Allergology, Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
Zitieren
APA
Boyarchuk, O., Dyvonyak, O., Hariyan, T., & Volokha, A. (2023). Case report: Virus-induced hemophagocytic lymphohistiocytosis in a patient with APECED. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1086867
Vancouver
Boyarchuk O, Dyvonyak O, Hariyan T, Volokha A. Case report: Virus-induced hemophagocytic lymphohistiocytosis in a patient with APECED. Frontiers in Pediatrics. 2023;11. doi:10.3389/fped.2023.1086867
BibTeX
@article{Boyarchuk2023,
author = {Boyarchuk, Oksana and Dyvonyak, Olha and Hariyan, Tetyana and Volokha, Alla},
title = {Case report: Virus-induced hemophagocytic lymphohistiocytosis in a patient with APECED},
journal = {Frontiers in Pediatrics},
year = {2023},
volume = {11},
doi = {10.3389/fped.2023.1086867}
}
EUVIMED